ReT01 ACT
/ Xinsheng Medicine
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 31, 2024
A Phase I Study on ReT01 ACT for the Treatment of Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=15 | Recruiting | Sponsor: Aeonvital Biomedicine | Not yet recruiting ➔ Recruiting
Enrollment open • Metastases • Oncology • Solid Tumor
February 14, 2024
A Phase I Study on ReT01 ACT for the Treatment of Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=15 | Not yet recruiting | Sponsor: Aeonvital Biomedicine
New P1 trial • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1